Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
about
Effect of medications on physical function and cognition in nursing home residents with dementiaSafety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Treatment of sleep disturbance in Alzheimer's dementia.Outpatient treatment of sleep disorders in Alzheimer patientsRadio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer diseaseCognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.Quetiapine safety in older adults: a systematic literature review.CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based studyDesigning a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.The validity of dependence as a health outcome measure in Alzheimer's diseaseAlternatives to atypical antipsychotics for the management of dementia-related agitation.A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.Contributions of environment, comorbidity, and stage of dementia to the onset of walking and eating disability in long-term care residents.
P2860
Q34103934-9A66D00F-9DD6-4916-95E5-38C4B9D6B57FQ34571959-70E96F8C-4FE5-48DB-B9B3-8C947560B293Q34623833-D7A13B84-9778-4566-96CE-A236862DDC4BQ34669691-E2B1268E-D2C0-4149-8476-1BA81C296483Q35137888-5E048E99-0435-44E5-BCA2-E0DA05FF8356Q35846062-3C24B759-4BE7-4E95-9D6D-F3661F875B63Q35905294-995E6A89-1DAE-4A64-90BE-2CA941C3E736Q35953332-3A935A35-B9F4-4CFA-B39D-5A8CFB1551B6Q36109984-EB551AD2-654D-4295-8C06-8757CB872392Q36710267-C78AD156-0E21-48F6-9490-DB1C2FA9BD57Q36949519-C96B9B3C-D811-4BFF-9F81-EFE70EDCC43BQ36949528-8575E61F-C086-4EF8-AC4E-09D65FACDBA7Q37151230-DC220643-C359-4A7F-A7A2-25E14F88FFA9Q38150568-F6805D34-6B85-4BAC-B0EA-34EB5B97F20AQ38720657-AEF311CB-A440-44AD-A829-15500012B278Q51322586-89CBD6C0-AB1E-4EBB-99CA-7851D3ECCB60
P2860
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@en
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@nl
type
label
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@en
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@nl
prefLabel
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@en
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@nl
P2093
P2860
P1476
Risperidone, olanzapine and qu ...... ralistic, retrospective study.
@en
P2093
Cristiana Montemagni
Davide Perrone
Federica Marino
Filippo Bogetto
P2860
P304
P356
10.1111/J.1440-1819.2007.01729.X
P50
P577
2007-12-01T00:00:00Z